These results provide further insights into the functions of FURIN in myeloid cells and suggest that monocyte/macrophage-specific targeted FURIN inhibition may be a useful therapeutic strategy for atherosclerosis and related disorders. The gene discussed is FURIN; the disease is atherosclerosis.